# Morphine, Dyspnea, Exercise and COPD

> **NCT01718496** · PHASE3 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Morphine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01718496
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718496, "Morphine, Dyspnea, Exercise and COPD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01718496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*